Katherine Hanlon

Dr. Katherine Hanlon is a Rita Allen Foundation scholar and an assistant professor of Biomedical Sciences at the University of New England College of Osteopathic Medicine in Biddeford, ME. In addition, she is an associate editor in chief of the Journal of Pain Research and is a scientific advisory board member at Exeligen Scientific. Dr. Hanlon received a B.S. in Biochemistry and Molecular Biophysics followed by a Ph.D. in Pharmacology at the University of Arizona. Under the direction of Dr. Todd Vanderah, her thesis work centered on the molecular mechanisms employed by cannabinoid receptor 2 selective compounds in breast cancer. Dr. Hanlon completed a postdoctoral fellowship in Tumor Immunology at the Icahn School of Medicine at Mount Sinai under the direction of Dr.'s Joshua Brody and Peter Heeger, where she investigated the efficacy of anti-CTLA4 primed immunotransplant in metastatic melanoma and the molecular signaling pathways surrounding the immunosuppressive activity of erythropoietin on human T-cells. Dr. Hanlon retains significant interest in targetable immune cell mechanisms, particularly in relation to tumor development and nociception.


B.S. Biochemistry and Molecular Biophysics

University of Arizona

Ph.D. Pharmacology

University of Arizona


Post-Doctoral Training

Tisch Cancer Institute

Mount Sinai Medical Center

New York

New York




tumor immunology


Current Research

The Hanlon lab explores macrophage differentiation and function in biological systems including the functional implications of neuro-immune communication between neuronal cell bodies and tissue resident macrophages in the dorsal root ganglia as it pertains to nociception and the functional control of tumor associated macrophages within the breast tumor microenvironment.

Research Interests

  • Neuro-immune communication between resident tissue macrophages and neuronal cell bodies in sensory ganglia, specifically as it impacts nociception.
  • Macrophage involvement in breast tumor development.
  • Restoration of immune homeostasis in the treatment of breast cancer.
  • Cannabinoid receptor 2 signaling in Macrophages, T-cells, and NK cells.

Dr. Hanlon

Katherine Hanlon



Assistant Professor


Pickus Center


(207) 602-2159

On Campus